The remarkable capacity of the bone marrow to regenerate and reconstitute haemopoiesis provides the rationale for bone marrow transplantation (BMT). Within a period of several weeks, infused (donor) stem cells re-establish haemopoiesis at normal physiologic sites (i.e. the bone marrow). However, little is known about the early fate of haemopoietic stem cells following their intravenous administration until re-establishment of haemopoiesis within the marrow space. Evidence exists for the involvement of adhesion molecules such as VLA-4 (Williams et al, 1991; Rosemblatt et al, 1991; Miyake et al, 1991) and VLA-5 (Rosemblatt et al, 1991) and VCAM-1 (Simmons et al, 1992) . Likewise, proteoglycans such as CD44, CD45 and Mac-1 also serve as ligands for speci®c adhesion receptors within the marrow microenvironment (Long, 1992; Coombe et al, 1994) . However, these molecules are widely expressed, and their speci®c role in cellular localization is unclear.
It has been suggested that intravenously infused haemopoietic stem and progenitor cells return to the bone marrow through a speci®c`homing' process (de®ned as the immediate, selective lodging of haemopoietic cells within the marrow space) that is mediated by the interaction of cellsurface receptors with corresponding glyco-conjugate ligands (Hardy & Tavassoli, 1988; Tavassoli & Hardy, 1990) . Moreover, the partial inhibition of BMT ef®ciency by mannosyl-and galactosyl-neoglycoproteins further implies that the putative homing receptor contains critical galactose and mannose residues (Aizawa & Tavassoli, 1988) .
In order to characterize the early events of marrow haemopoietic cell traf®cking following BMT, we monitored intravenously infused donor bone marrow cells (albeit phenotypically unde®ned) by three different means: 111 Indium labelling,¯uorescent labelling using the membrane-bound dye PKH26, or the use of a donor-cell-speci®c transgene marker detected by PCR. Early traf®cking of infused donor cells was observed in the marrow of the recipient mice, as well as in all other tissues examined. Importantly, signi®cant differences were observed in bone marrow cell traf®cking for irradiated versus nonirradiated BMT recipients. Infusion of PKH26-labelled cells that had localized to the bone marrow of the primary donor into secondary recipients resulted in a similar tissue distribution pattern, with no increase in the percentage of cells returning to the marrow. These results suggest that bone marrow cells do not speci®cally home to the marrow in the period immediately following transplantation.
MATERIALS AND METHODS
Bone marrow transplantation. 8±12-week-old male C57BL/6J mice (Jackson Laboratories) were used for the 111 In labelling, and the PKH26-labelled bone marrow transplantation studies. Transgenic mice carrying a murine PAI-1 transgene under control of the cytomegalovirus (CMV) promoter were used for the transgene-marker PCR studies (Eitzman et al, 1996) . Although the original transgenic founder mouse was SJL/J´C57BL/6J, all transgenic mice used in these studies were the product of more than ®ve backcrosses to the C57BL/6J parental strain. All mice were maintained under speci®c pathogen-free (SPF) conditions.
Where indicated, recipient mice were lethally irradiated with a total dose of 10´5 grays 24 h prior to transplantation using a 135 Cs irradiation source (Gammacell 40, Nordion International) fractionated into an initial dose of 7 grays followed by 3´5 grays at 4 h. For the 111 In and transgene marker studies, BMTs were performed by infusion via the tail vein of 10 7 nucleated marrow cells into each non-irradiated or irradiated primary recipient animal. In the case of secondary transplants (of PKH26-labelled cells, see below), a total of 5´10 5 pooled, marrow cells from the primary recipient (taken post-irradiation and transplant) were intravenously administered into irradiated secondary recipients. Donor bone marrow cells were obtained as previously described (Long & Shapiro, 1985) , and red blood cells (RBC) were removed by incubation with RBC lysis buffer (145 mM NH 4 Cl, 10 mM KHCO 3 and 0´1 mM EDTA), followed by washing with phosphate-buffered saline (PBS).
Labelling of donor bone marrow cells by 111 In, and RBC with technetium-99 ( 99 Tc). Bone marrow NALD cells were isolated from mouse femurs as described previously (Long & Shapiro, 1986) and labelled with 111 In (Medi-Physics Inc., Livonia, Mich.). For labelling, 111 In was added to the cell suspension and incubated at room temperature for 20 min (Thakur et al, 1977) . Labelled cells were washed twice in Hanks' Balanced Salt Solution (HBSS, from Sigma Chemical Co., St Louis, Mo.), and resuspended in 1 ml HBSS. During each wash, cells were collected by centrifugation at 400 g for 7 min at 48C. After two rinses, the unbound 111 In was < 8%, and the labelling ef®ciency was 40%. Cell viability following labelling was > 95%, as measured by trypan blue exclusion. Tc tissue/blood counts. This calculation was performed on each tissue from each individual recipient animal in each group (irradiated and non-irradiated) and was analogous to the speci®c localization ratio for antibody targeting (Wahl et al, 1983) . Statistical analysis was performed using Student's t-tests.
Labelling murine bone marrow cells with PKH26. Cell labelling with PKH26, a¯uorescent membrane dye, was performed according to the manufacturer's instructions (Sigma, St Louis, Mo.). To de®ne the optimal conditions for labelling murine bone marrow cells, PKH26 concentrations of 2, 5, 10 and 20 mM were tested. Dye concentrations of > 2 mM were associated with signi®cant fractional cell death as assayed by trypan blue exclusion. Optimal labelling was obtained following incubation of 1±5´10 7 marrow cells/ml in 2 mM PKH26 for 2 min at room temperature.
Flow cytometric analysis of PKH26-labelled bone marrow samples. Bone marrow cells of recipient animals were harvested from both femurs at various time points following injection. After removal of RBCs by osmotic lysis, bone marrow samples were ®xed with 1% paraformaldehyde in PBS for analysis using a Coulter Epics Elite Flow Cytometer (Coulter Corporation, Hialeah, Fla.) with an excitation wavelength of 514 nM and an emission wavelength of 575 nM. The following formula was used to calculate the seeding ef®ciencies (SE) of infused donor marrow cells: SE (%) (PK´TM/TD)´100, where PK the percentage of PKH26-positive cells in the recipient marrow sample as determined by FACS analysis; TM the number of nucleated marrow cells in the total marrow space of the recipient mouse; this number was estimated to be 1´7´10 8 for nonirradiated and 1´7´10 6 for irradiated hosts, based on average cell counts of both femurs from ®ve animals, and assuming each femur to contain 6% of total marrow (Chervenick et al, 1968) and TD total number of infused, PKH26-labelled donor cells. DNA extraction and PCR ampli®cation to detect donor cells. Femoral marrow cells and peripheral blood, along with sections of liver, lung, spleen and kidney, were collected from euthanized recipient mice, and total cellular DNA was prepared using standard methods (Sambrook et al, 1989 H CCTACACAACGAAGAGGTCC3 H ) were designed to amplify a 290 bp segment of vector-speci®c sequence within the PAI-1 transgene. PCRs were performed (Kakuta et al, 1986) using 200 ng of each primer in a volume of 50 ml for 35 cycles. The PCR product was visualized by ethidium bromide staining after electrophoresis in 4% NuSieve agarose gels (FMC Bio Products, Rockland, Maine). Negative control reactions (no added DNA template) were routinely included. These control lanes were consistently negative for all PCR experiments.
RESULTS

Detection of donor cells in various tissues by
111 In labelling The tissue-speci®c localization (TSL) of bone marrow derived non-adherent low-density (NALD) cells following transplantation of 111 In and 99 Tc-labelled cells is shown in Figs 1 and 2. A speci®c signal was detected in all tissues examined, but a number showed relatively low degrees of tissue localization. These include kidney, heart, skeletal muscle, fat and small intestine (latter two not shown). None of the localization signals in these ®ve tissues were signi®cantly different from each other (P < 0´05). In contrast, tissues with a known predilection for accumulating labelled granulocytes (Thakur et al, 1977) showed increased cellular localization of (granulocyte-depleted) NALD cells. For the non-irradiated recipients, signi®cant NALD cell localization (compared to the relatively low localization to the heart; so chosen as the heart had an intermediate absolute localization signal of the aforementioned`low-localization' tissues) was seen in bone marrow, spleen and liver 4 h following the injection (Fig 1,  upper panel) . At 24 h, there was a continuing rise in NALD cell traf®cking in most tissues (Fig 2, upper panel, note difference in Y-axis scale). In the irradiated recipients, In, and donor red blood cells were labelled with 99 Tc as described in Methods. 4 h following simultaneous intravenous administration of both cell types into non-irradiated (upper panel) and irradiated (lower panel) hosts, tissue samples were obtained from euthanized animals, and the tissue-speci®c localization index calculated as described in Methods. * P < 0´05 compared to the myocardium. speci®c localization (in excess of that occurring in the heart) occurs within 4 h, and was seen in a variety of tissues: bone marrow, spleen, kidney, liver and lung (Fig 1, lower panel) . These tissues also continued to show signi®cant localization at 24 h, though the relative accumulation of labelled cells is markedly increased (Fig 2, lower panel , note change in Y-axis scale). Comparison of 4 h and 24 h data indicated that signi®cant increases in tissue localization occurred in both`haemopoietic' tissues (bone marrow, spleen and liver) and in non-haemopoietic tissues (kidney, lung, heart and muscle; compare Figs 1 and 2) . However, the magnitude of the change in TSL was not greatly different between these two types of tissue, and was often equivalent or higher in non-haemopoietic tissues. Taken as a whole, the TSL data indicate that intravenously injected NALD cells showed no speci®city for haemopoietic microenvironments (or microenvironments with haemopoietic potential) during the ®rst 24 h following infusion.
PCR detection of infused bone marrow cells in multiple tissues
For these experiments, donor bone marrow cells were harvested from a transgenic mouse line carrying an inert PAI-1 transgene. Host animals were killed at varying times following transplantation, and tissue samples (from blood, marrow, liver, lung, spleen and kidney) were examined by PCR using oligonucleotide primers speci®c for transgene sequences. As with the 111 In/
99
Tc studies, a transgene signal was obtained from bone marrow, peripheral blood, liver and spleen DNAs at all time points (Fig 3) , with similar signals also observed in lung and kidney (data not shown). A constant signal was evident at later time points in bone marrow and spleen DNA, demonstrating that a persistent proportion of donor cells was localized in these two tissues (Fig 3) , whereas the signal from liver and blood diminished somewhat after 20 h. The decreased signal from blood was consistent with a continued gradual migration of donor cells out of the peripheral circulation, and suggests that donor marrow cells rapidly leave the circulation following infusion, migrating into multiple organs and tissues.
PKH26 labelling of murine bone marrow cells
The PKH26 dye stably and irreversibly labelled the lipid component of the cell membrane for a broad range of cell types, without signi®cant exchange between cells, and without apparent interference with cellular function or surface protein structure (Slezak & Horan, 1989; Samlowski et al, 1991; Ricketts et al, 1992) . In addition, Hendrikx et al (1996) demonstrated that the presence of the PKH26 dye did not interfere with the formation of day 8 and day 12 spleen colonies in lethally irradiated mice.
Bone marrow from recipient mice was collected at 15, 25 and 40 h post transplantation, and analysed for the presence (Table I) localized to the bone marrow of non-irradiated recipients within 15 h following injection. Though a larger¯uorescence peak was seen at 15 h in irradiated mice (Fig 4C) , compared to the similar experiments in non-irradiated hosts (Fig 4B) , this was due to the marked decrease in the number of unlabelled host cells following irradiation. Calculations based on correction for numbers of unlabelled host cells indicated that approximately 3% of the infused donor cells localized to the marrow of irradiated recipients (Table I) . For both groups of animals, maximal localization of infused cells to the marrow appeared to have been reached by the ®rst time point (15 h), with no signi®cant changes in the percentage of cells localizing to the marrow at up to 40 h (data not shown).
Within 15 h of transplantation, signi®cant differences in donor-cell¯uorescence intensity were seen in irradiated versus non-irradiated recipients (compare Figs 4B and 4C) . In non-irradiated animals approximately 65% of the donor cells retain PKH26 staining equivalent to that of the input cells, whereas¯uorescent intensity of the remaining 40% of cells was reduced by approximately one-half the original, which suggested that these cells had completed approximately one round of cell division. In contrast, the donor cells detected in irradiated recipients (Fig 4C) exhibited¯uores-cent intensities of one-quarter to one-half that of input cells, demonstrating a greater degree of donor cell proliferation in these animals.
Failure of bone marrow localization to enrich for a speci®c homing' subpopulation In an effort to enrich for a subpopulation of donor cells capable of speci®cally homing to the recipient marrow, cells localized to the bone marrow in the ®rst transplant recipient were collected and infused into secondary recipient animals. For these experiments, PKH26-labelled cells were ®rst injected intravenously into an irradiated primary host, and unfractionated bone marrow cells were collected from the femurs of recipient animals 15 h following the ®rst transplant. These cells were then intravenously infused into irradiated secondary recipients. The secondary recipients were killed at 15 h, and femoral bone marrow cells were collected. Flow cytometric analysis of bone marrow cells from the secondary recipient detected only very small numbers of PKH26-labelled cells derived from the original donor animal (< 0´1%). Calculations of seeding ef®ciency (Table I) indicated that < 3% labelled cells isolated from the marrow of the ®rst recipient again localized to the marrow in the secondary recipient. This value did not represent a signi®cant enrichment over the fraction of cells that localized to the primary recipient marrow. Thus, cell migration to the bone marrow of the primary transplant recipient failed to enrich for a subpopulation of cells capable of again speci®cally homing to the marrow of the secondary recipient. Analysis of experiments using non-irradiated primary and secondary recipients similarly failed to demonstrate signi®-cant enrichment of a speci®c homing subpopulation. To some degree, however, the high background of unlabelled cells could have obscured detection of marrow enrichment in these latter experiments. Also a formal possibility remains that, at 30 h post labelling, the PKH26-marked cells proliferated (in irradiated recipients) to a degree that their uorescence-intensity was close to background and thus the cells were undetectable as originally labelled cells. We believe that this is unlikely, given the high¯uorescence intensity of the PKH26-labelled cells (Fig 4A) , and the data showing that the majority of cells undergo a single population doubling (Fig 4C) . Thus, even three population doublings would yield a signal well above background (i.e. one-eighth that of original, within the second decade of the¯uorescence histogram).
DISCUSSION
The localization of infused donor cells to the host marrow is a critical component of BMT engraftment, and the reconstitution of host haemopoiesis. A number of laboratories have presented data to support the existence of a speci®c homing receptor on the haemopoietic stem cell, with a corresponding ligand being present on the marrow endothelial cell and/or the marrow stroma. Our observations, demonstrating early localization of up to 17% of infused donor cells to the marrow of non-irradiated recipients, suggest that a broad range of phenotypically unde®ned bone marrow cells are capable of initially localizing to the marrow, as well as other organs. The subsequent failure to enrich for a homing subpopulation in the secondary serial transplant was unexpected, and argues against the existence of a speci®c, highly ef®cient,`homing' mechanism. Thus, the analysis of early NALD cell traf®cking using both 111 In labelling and PCR detection of a marker transgene demonstrated that, within as little as 3 h, injected cells leave the circulation and migrate into a diverse number of organs and tissues in an apparently nonspeci®c pattern. Other PKH26-labelling studies, utilizing more puri®ed subpopulations of haemopoietic cells, showed a similar temporal movement (i.e. within 3 h) of haemopoietic stem and/or progenitor cells into the bone marrow or spleen (Lanzkron et al, 1999; Szilvassy et al, 1999) . However, these investigations did not monitor cell traf®cking into other (non-haemopoietic) tissues. Interestingly, the NALD cell tissue distribution pattern observed in our study was very similar to that seen by the infusion of 111 In-labelled autologous peripheral blood leucocytes in humans, where the spleen, liver, lungs and marrow represent the site of greatest tracer (cell) accumulation (Thakur et al, 1977) . This suggests that general mechanisms of vascular egress regulate the early events of phenotypically unde®ned marrow cell traf®cking following intravenous infusion.
The increased uptake of 111 In-labelled NALD cells to a variety of tissues in irradiated mice relative to non-irradiated animals is probably due to the increase in general vascular permeability seen following total body irradiation of this magnitude (i.e. capillary leak) (Vriesendorp et al, 1994; Aizawa & Tavassoli, 1988) . Although the subset of PKH26-labelled cells from the original donor detected in the secondary recipient by FACS analysis (< 0´1%) was near the limit of sensitivity for this assay, the predicted signi®cant increase in the percentage of speci®c homing cells was not observed. However, we cannot exclude the existence of a small subpopulation of cells (e.g. stem cells) which does ef®ciently home to the marrow, but was obscured by the nonspeci®c movement of the large background of other marrow cells.
Consistent with a recent report of utilizing PKH26 labelling (Hendrikx et al, 1996) , we observed higher numbers of PKH26-labelled donor cells in the marrow of non-irradiated recipients than in irradiated animals. However, unlike that study, we observed a majority of cells in nonirradiated hosts that remained quiescent, whereas 40% underwent proliferation. The reason for the difference between these two studies is not clear, but may be related to the 5-fold differences in PKH26-labelling concentration, or other technical variations. Moreover, Hendrikx et al (1996) utilized an antigenically de®ned population of cells enriched in stem cell activity whereas our study employed non-adherent low-density cells. This latter cell population consists of > 99% lymphoid cells and contains very few mature myeloid cells that would readily egress into tissues and represent a`false positive' signal. This difference in cell populations undoubtedly accounts for the localization differences. However, it is interesting to note the similarities in traf®cking: both populations performed better in non-myeloablated recipients, and both showed evidence of cell traf®cking into organs other than the marrow.
Our intent was to examine the traf®cking of bone marrow NALD cells to determine if localization speci®city or transplant-mediated enrichment could be observed at this level of`resolution', and this was not the case. Hendrikx et al (1996) also noted a (calculated) speci®c localization index for cells localizing to the marrow, that was higher than that of cells localizing to the spleen, suggesting that speci®c homing' had occurred, especially for the enriched population of cells used in that study. However, their study also observed cells in the liver, demonstrating that cells also localized to this tissue. Given that the sensitive PCR and indium-labelling studies reported here showed a rapid egress to all tissues, and that the secondary bone marrow transplant of labelled cells failed to speci®cally enrich a population of donor cells, we believe that non-speci®c tissue migration plays a previously unappreciated role in early haemopoietic cell traf®cking.
Our data are consistent with a number of investigations suggesting that no preferential selection of haemopoietic cells occurs within the bone marrow. Papayannopoulou et al (1995) demonstrated that selective modulation of bone marrow cell traf®cking (at 3 h) was mediated by the VLA4/ VCAM-1 integrin system, but that other cytoadhesion molecules also played a role in bone marrow localization. Their observations, in turn, were in agreement with earlier studies that reported the presence of haemopoietic progenitor cells in many tissues (lung, liver, kidney, spleen, blood and bone marrow) shortly following cell infusion into irradiated recipients (Vos et al, 1972; Kretchmar & Conover, 1969; Lahiri & Van Putten, 1969) . Our data con®rm and extend these observations indicating that donor bone marrow cells localize to most tissues, for periods of up to 48 h following infusion. Taken together, these investigations argue against the preferential uptake of haemopoietic cells by the bone marrow. None of these studies, however, distinguish between the preferential retention of haemopoietic progenitor cells in haemopoietic tissues (after 48 h), or a preferential survival and proliferation within a haemopoietic microenvironment.
Myeloablation is assumed to be a necessary prerequisite for bone marrow transplantation that ensures removal of host cells and the creation of appropriate niches for engrafting donor cells (Scho®eld, 1978; Takada et al, 1971; Micklem et al, 1968) . However, several studies have shown that donor cells are capable of stable engraftment, even without prior chemotherapy, or radiation (Takada et al, 1971; Brecher et al, 1979; Micklem et al, 1968; Quesenberry et al, 1994) , suggesting that marrow spaces (`niches') do not have to be created to ensure engraftment. Our PKH26-labelling data and that of Hendrikx et al (1996) suggest that immediate traf®cking of infused bone marrow cells to the marrow space is inhibited by prior radiation, possibly due to damage to the marrow sinusoidal endothelial cells, or damage to other components of the haemopoietic microenviroment. The 111 In-labelling studies con®rmed this concept, showing increased tissue speci®c localization in a number of tissues that was similar to cell-distribution patterns observed when 111 In-labelled granulocytes were infused (Thakur et al, 1977) . We conclude that an early adverse affect of irradiation might not be appreciated in the standard stem cell transplant protocols, as successful engraftment generally is not assessed until a much later time point. Based on the above data, we hypothesize that the early migration of infused marrow cells may represent nonspeci®c seeding' rather than a speci®c homing process. Infused marrow cells, at many stages of differentiation, may ®rst adhere to vascular endothelial cells, and exit the circulation nonspeci®cally into many tissues. In this model, infused marrow cells would be distributed to all tissues randomly, but only those within the bone marrow would encounter the appropriate environment for proliferation and differentiation. Though this model is consistent with our observations of phenotypically unde®ned marrow cell traf®cking at early time points, we cannot exclude a more complex speci®c homing process requiring prior cell processing in other tissues, or later changes in the cell surface, to selectively localize cells to the marrow. We conclude that bone marrow cell traf®cking is a complex multifaceted process, and that the ef®cient targeting of transplanted cells to the marrow cannot be explained by a simple single receptor/ligand interaction.
